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INTRODUCTION
The emergence of recombinant DNA technology during the early
70’s set a revolution in molecular biology. This set of techniques
was strengthened even further later on with the introduction of
the polymerase chain reaction and allowed scientists to explore
and understand essential life processes in an easy and straight-
forward way. It also marked the birth of the modern biotech
industry. At that time, it was shown that eukaryotic DNA could
be propagated in Escherichia coli (Morrow et al., 1974) and func-
tional products could be synthesized from heterologous genes
cloned in bacterial plasmids (Ratzkin and Carbon, 1977; Vapnek
et al., 1977). After these successful cases, it was soon realized
that the potential applications of these techniques were almost
limitless. In fact, US patent 4,237,224 granted to Cohen and
Boyer (1980) claimed to commercial ownership of the method-
ology for cloning virtually all possible DNAs in all possible
vectors. While cloning any gene in any given vector is feasible,
obtaining a functional product from its expression is not that
simple.
In this series of articles, the authors describe the methods and
technologies available for producing recombinant proteins in dif-
ferent microbes. They also introduce and discuss recent advances
that attempt to tackle common pitfalls in the process. Taken
together, this E-book will be of great importance for those enter-
ing the field as well as for experienced researchers that are looking
for an update in the state of the art.
Before proceeding any further, it is necessary to clarify
an important aspect of this topic. In biology, the univer-
sal accepted definition of “expression” is “production of an
observable phenotype by a gene—usually by directing the syn-
thesis of a protein” (Alberts et al., 2002). By this definition,
the term “gene expression” is correct while “protein expres-
sion” is basically lab jargon. We do think that correct usage
of scientific language is of great importance, yet in this par-
ticular case, the usage of “protein expression” in the scien-
tific community is so pervasive that readers will immediately
understand what we are talking about. So, considering that “pro-
tein expression” found its way into journal names, book names
and high-impact reviews (Sørensen and Mortensen, 2005) and
research papers (Ghaemmaghami et al., 2003) (>1800 citations
in Scopus) we and other authors have used it interchangeably
with more correct terms like protein production or protein
synthesis.
CURRENT STATUS IN RECOMBINANT PROTEIN
EXPRESSION IN MICROBIAL SYSTEMS
Without a doubt, E. coli is the most widely used host for het-
erologous gene expression. It has been used for this purpose for
more than 40 years, so there is much accumulated knowledge
about its advantages and disadvantages as an expression platform.
Rosano and Ceccarelli review the tools at hand (expression vec-
tors, strains, media composition, etc.) when using E. coli as a host
(Rosano and Ceccarelli, 2014). Different approaches for solving
common problems, such as inclusion body (IB) formation or low
yield, are also presented.
Other authors delve a little deeper into these issues. Costa
and coauthors give a thorough description of different fusion
tags that can be appended to the target protein in order to
increase its solubility and/or ease its purification from the cel-
lular milieu (Costa et al., 2014). Along this line, Correa and
coauthors present a very promising approach to straightforwardly
assess the solubility of a recombinant protein by cloning the
corresponding gene in 12 different expression vectors in paral-
lel (Correa et al., 2014). Even though IB formation is mainly
regarded as a nuance in the production of recombinant proteins,
Ramon and coworkers make the case that this is not always true
and focus on the positive side of IBs, highlighting the advan-
tages of producing recombinant proteins as IBs for basic and
applied research (Ramon et al., 2014). No or low yield can be
the result of codon bias and Elena and coauthors look into
one of the strategies used for solving this problem, the expres-
sion of codon optimized genes (Elena et al., 2014). Of great
importance is their account of the application of this technol-
ogy in the industrial setting. Not always the desired product
is a protein, sometimes metabolites and fine chemicals are the
goal. The review of Ceccoli and coauthors details with numerous
examples how E. coli and other microorganisms can be turned
into biocatalysts by strain engineering (Ceccoli et al., 2014).
High-value products can thus be obtained from pure recombi-
nant enzyme or from whole-cell systems, turning the host into
an exquisitely designed and environmentally friendly chemical
factory.
ADVANCES IN NEW TECHNOLOGIES
Microbes other than E. coli can be used for heterologous pro-
tein production. The impact of yeasts on the biotech industry is
paramount, as 20% of biopharmaceutic proteins are synthesized
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in yeasts. But still, they are not the first-choice microorganism
for recombinant protein production. In her Perspective article,
Bill arguments that the yeasts Saccharomyces cerevisiae and Pichia
pastoris should be considered alongside E. coli in any project in
need of a recombinant protein (Bill, 2014). Filamentous fungi
are excellent protein secretors, a property that makes them ideal
as a host at an industrial scale. Nevalainen and Peterson present
an authoritative review describing the body of research carried
out into cellular mechanisms of fungi that will ultimately lead
to the optimization of the system (Nevalainen and Peterson,
2014). Specht and Mayfield explain the usefulness of microalgae
as expression systems, focusing on the production of recombinant
vaccines (Specht and Mayfield, 2014). The quest for edible vac-
cines is an active area of research and microalgae will definitely
play a major role as they possess greater advantages over plants
(which can also be used for this purpose) in terms of cost, safety,
and logistics.
AFTERWORD
After getting into all the articles in this E-book, it should be clear
to the reader that progress in the field of recombinant protein
expression in microbial systems shows no sign of deceleration.
Their use and importance in research and in industry cannot be
disputed. Their establishment in the bio(techno)logy toolkit was
due to the ongoing efforts of researchers that continuously opti-
mize well-known systems such as E. coli and those who break
new ground in the use of alternative microorganisms. We want
to take this opportunity to thank all the experts of this series for
their excellent contributions and the reviewers for their insightful
comments and remarks.
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